Key Insights
The Brazilian contraceptive devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 6.70% from 2025 to 2033. This expansion is driven by several key factors. Increasing awareness of family planning and reproductive health, coupled with government initiatives promoting access to contraceptives, are significantly boosting market demand. Furthermore, the rising prevalence of sexually transmitted infections (STIs) and the need for effective prevention are contributing to higher adoption rates. The market is segmented by type (condoms, diaphragms, IUDs, etc.) and gender, with condoms and IUDs likely dominating due to their widespread accessibility and effectiveness. Growing urbanization and improved healthcare infrastructure are also positively impacting market penetration. However, certain restraints exist, including cultural and religious beliefs that limit contraceptive use in some segments of the population, along with potential challenges in distribution and affordability in more remote areas. Despite these limitations, the long-term outlook remains positive, fueled by continuous improvements in contraceptive technology and ongoing educational campaigns focused on responsible family planning.
The competitive landscape is characterized by a mix of multinational pharmaceutical giants and specialized contraceptive manufacturers. Companies like AbbVie Inc (Allergan PLC), Ansell Ltd, Bayer AG, Reckitt Benckiser Group plc, Johnson & Johnson, and Pfizer Inc hold significant market shares, leveraging their established distribution networks and brand recognition. However, smaller, specialized companies are also emerging, often focusing on innovative product development and niche market segments. These companies will likely contribute to market diversification and increased competition in the coming years. Future growth will hinge on the successful implementation of government policies, sustained investment in healthcare infrastructure, and the continued development of accessible and effective contraceptive options tailored to the specific needs of the Brazilian population. Addressing affordability concerns and tackling societal barriers remains crucial for realizing the market's full potential.
Brazil Contraceptive Devices Industry: Market Report 2019-2033
This comprehensive report provides a detailed analysis of the Brazil contraceptive devices market, covering market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period spans from 2019 to 2033, with a base year of 2025 and a forecast period of 2025-2033. The report utilizes both qualitative and quantitative data to offer valuable insights for industry professionals, investors, and stakeholders.

Brazil Contraceptive Devices Industry Market Dynamics & Structure
The Brazilian contraceptive devices market is characterized by a moderately concentrated landscape with several multinational and domestic players vying for market share. Technological innovation, primarily focused on efficacy, safety, and user experience, plays a crucial role. The regulatory framework, governed by Anvisa (National Health Surveillance Agency), significantly influences product approval and market access. Competitive substitutes, including traditional methods, impact market penetration. The end-user demographic is predominantly female, with age and socioeconomic factors influencing product preference. Mergers and acquisitions (M&A) activity has been relatively moderate in recent years, with xx deals recorded between 2019-2024.
- Market Concentration: Moderately concentrated, with top 5 players holding xx% market share (2024).
- Technological Innovation: Focus on improved efficacy, reduced side effects, and user-friendly designs.
- Regulatory Framework: Stringent regulations by Anvisa impacting product approvals and market entry.
- Competitive Substitutes: Traditional methods like withdrawal and fertility awareness pose competition.
- End-User Demographics: Primarily female, varying by age group and socioeconomic status.
- M&A Activity: xx deals between 2019-2024, indicating moderate consolidation.
Brazil Contraceptive Devices Industry Growth Trends & Insights
The Brazilian contraceptive devices market experienced a Compound Annual Growth Rate (CAGR) of xx% during the historical period (2019-2024), driven by increasing awareness of family planning and government initiatives promoting reproductive health. Market penetration for modern contraceptive methods remains below xx%, indicating significant untapped potential. Technological advancements, such as the introduction of long-acting reversible contraceptives (LARCs) like IUDs, have contributed to market expansion. Shifting consumer preferences towards convenient and effective options are also key growth drivers. Increased access to healthcare and information campaigns further fuel market growth. The projected CAGR for 2025-2033 is xx%, fueled by continued government initiatives, improved healthcare access, and rising awareness.

Dominant Regions, Countries, or Segments in Brazil Contraceptive Devices Industry
The Brazilian contraceptive devices market shows significant regional variations, with higher adoption rates in more developed urban areas compared to rural regions. By product type, condoms remain the most dominant segment, representing xx million units in 2024, driven by affordability and accessibility. However, the IUD segment exhibits the highest growth rate, fueled by government initiatives like the June 2022 USD 95 million investment in IUD placement procedures. By gender, the female segment dominates, accounting for xx million units in 2024.
- Key Drivers (IUD Segment): Government initiatives, increased awareness of long-term effectiveness, and improved healthcare access.
- Dominance Factors (Condoms): Affordability, accessibility, and widespread availability.
- Growth Potential (IUD): High, driven by government support and increasing awareness among young women.
Brazil Contraceptive Devices Industry Product Landscape
The Brazilian contraceptive devices market offers a diverse range of products, including condoms, pills, IUDs, implants, and other methods. Recent innovations focus on improving efficacy, reducing side effects, and enhancing user experience. Products featuring extended-use formulations and improved delivery systems are gaining traction. The market shows a growing preference for discreet, convenient, and long-acting methods.
Key Drivers, Barriers & Challenges in Brazil Contraceptive Devices Industry
Key Drivers:
- Increasing awareness of family planning and reproductive health.
- Government initiatives promoting access to contraceptives.
- Rising disposable incomes and improved healthcare infrastructure in certain regions.
- Technological advancements resulting in more effective and user-friendly products.
Key Challenges:
- Limited access to healthcare in remote areas.
- High cost of some advanced contraceptive methods limiting affordability.
- Misinformation and cultural barriers hindering adoption.
- Supply chain disruptions impacting product availability in certain regions.
Emerging Opportunities in Brazil Contraceptive Devices Industry
- Expanding access to contraceptives in underserved populations through public-private partnerships.
- Growing demand for digital health solutions providing remote access to family planning information and services.
- Increasing focus on male contraceptive methods, representing a relatively untapped market.
- Development of innovative products tailored to specific demographic needs.
Growth Accelerators in the Brazil Contraceptive Devices Industry
Sustained market growth will be fueled by ongoing government initiatives, the introduction of newer, more effective contraceptives, and improved accessibility. Strategic partnerships between public and private entities will enhance distribution networks and improve affordability. Continued investment in reproductive health education will play a pivotal role in expanding market awareness and driving adoption of modern contraceptive methods.
Key Players Shaping the Brazil Contraceptive Devices Industry Market
- AbbVie Inc (Allergan PLC)
- Ansell Ltd
- Veru Inc (The Female Health Company)
- Bayer AG
- Reckitt Benckiser Group plc
- Johnson & Johnson
- Merck & Co
- Church & Dwight Co Inc
- The Cooper Companies Inc
- Pfizer Inc
Notable Milestones in Brazil Contraceptive Devices Industry Sector
- August 2022: Anvisa approved Nextela, a new contraceptive pill with a formulation designed to minimize side effects.
- June 2022: The Ministry of Health invested USD 95 million in 31,600 IUD placement procedures.
In-Depth Brazil Contraceptive Devices Industry Market Outlook
The Brazilian contraceptive devices market is poised for significant growth over the forecast period, driven by a confluence of factors including increased awareness, government support, and technological advancements. Strategic partnerships, expansion into underserved regions, and the introduction of innovative products will unlock substantial market potential. Focusing on affordability and accessibility will be crucial for maximizing market penetration and improving reproductive health outcomes across Brazil.
Brazil Contraceptive Devices Industry Segmentation
-
1. Type
- 1.1. Condoms
- 1.2. Diaphragms
- 1.3. Cervical Caps
- 1.4. Sponges
- 1.5. Vaginal Rings
- 1.6. Intra Uterine Device (IUD)
- 1.7. Other Devices
-
2. Gender
- 2.1. Male
- 2.2. Female
Brazil Contraceptive Devices Industry Segmentation By Geography
- 1. Brazil

Brazil Contraceptive Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.70% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies
- 3.3. Market Restrains
- 3.3.1. Side Effects Associated with the Use of Contraceptive Devices
- 3.4. Market Trends
- 3.4.1. Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Brazil Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Condoms
- 5.1.2. Diaphragms
- 5.1.3. Cervical Caps
- 5.1.4. Sponges
- 5.1.5. Vaginal Rings
- 5.1.6. Intra Uterine Device (IUD)
- 5.1.7. Other Devices
- 5.2. Market Analysis, Insights and Forecast - by Gender
- 5.2.1. Male
- 5.2.2. Female
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Brazil
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 AbbVie Inc (Allergan PLC)
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Ansell Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Veru Inc (The Female Health Company)
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Bayer AG
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Reckitt Benckiser Group plc
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Johnson & Johnson
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Merck & Co *List Not Exhaustive
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Church & Dwight Co Inc
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 The Cooper Companies Inc
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Pfizer Inc
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 AbbVie Inc (Allergan PLC)
List of Figures
- Figure 1: Brazil Contraceptive Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Brazil Contraceptive Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 3: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 4: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 7: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 8: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Brazil Contraceptive Devices Industry?
The projected CAGR is approximately 6.70%.
2. Which companies are prominent players in the Brazil Contraceptive Devices Industry?
Key companies in the market include AbbVie Inc (Allergan PLC), Ansell Ltd, Veru Inc (The Female Health Company), Bayer AG, Reckitt Benckiser Group plc, Johnson & Johnson, Merck & Co *List Not Exhaustive, Church & Dwight Co Inc, The Cooper Companies Inc, Pfizer Inc.
3. What are the main segments of the Brazil Contraceptive Devices Industry?
The market segments include Type, Gender.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies.
6. What are the notable trends driving market growth?
Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Side Effects Associated with the Use of Contraceptive Devices.
8. Can you provide examples of recent developments in the market?
August 2022: The National Health Surveillance Agency (Anvisa) approved a new contraceptive pill whose formulation is meant to be less harmful to women's bodies and lower the risk of thrombosis. According to the Libbs (Manufacturer), it is anticipated to arrive on store shelves in Brazil between 2023 and 2024 under the brand Nextela.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Brazil Contraceptive Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Brazil Contraceptive Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Brazil Contraceptive Devices Industry?
To stay informed about further developments, trends, and reports in the Brazil Contraceptive Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence